NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Dorman Products, Inc. (NASDAQ: DORM) on behalf of Dorman stockholders. Our investigation concerns whether Dorman has violated the federal securities laws and/or engaged in other unlawful business practices.
Click here to participate in the action.
On February 24, 2020, Dorman announced its fourth quarter and full year 2019 financial results which included “an estimated pre-tax charge of $2.8 million related to the underpayment of duties to U.S. Customs arising from the misclassification of certain imported products over a five-year period.”
On this news, Dorman’s share price fell by $10.35, to close at $66.34 on February 24, 2020.
If you purchased or otherwise acquired Dorman shares and suffered a loss, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato or Marion Passmore by email at email@example.com, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.